Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tracleer in patients with Down syndrome and Eisenmenger reaction
2005-005584-28Phase 4Terminated
- Sponsor
- Pediatric Cardiology
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bosentan in pulmonary arterial hypertension (PAH), Eisenmenger syndrome and Down syndrome, sponsored by Pediatric Cardiology. Primary endpoint: Change in systemic oxygen saturation (tcSAT). Started Feb 2006; status: terminated.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)Eisenmenger syndromeDown syndrome
Beyond the preview
Go deeper on 2005-005584-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005584-28.